This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
other
product name :
CardioTACS In Situ Apoptosis Detection Kit
catalog :
4827-30-K
quantity :
30 Tests
price :
509 USD
citations: 19
Reference
Fu T, Mohan M, Bose M, Brennan E, Kiriazis H, Deo M, et al. Lipoxin A4 improves cardiac remodeling and function in diabetes-associated cardiac dysfunction. Cardiovasc Diabetol. 2024;23:413 pubmed publisher
Zoico E, Giani A, Saatchi T, Rizzatti V, Mazzali G, Fantin F, et al. Myocardial Fibrosis and Steatosis in Patients with Aortic Stenosis: Roles of Myostatin and Ceramides. Int J Mol Sci. 2023;24: pubmed publisher
Yan M, Cao Y, Wang Q, Xu K, Dou L, Huang X, et al. miR-488-3p Protects Cardiomyocytes against Doxorubicin-Induced Cardiotoxicity by Inhibiting CyclinG1. Oxid Med Cell Longev. 2022;2022:5184135 pubmed publisher
Liu Y, Zhou L, Du B, Liu Y, Xing J, Guo S, et al. Protection against Doxorubicin-Related Cardiotoxicity by Jaceosidin Involves the Sirt1 Signaling Pathway. Oxid Med Cell Longev. 2021;2021:9984330 pubmed publisher
Al Salam S, Hashmi S, Jagadeesh G, Tariq S. Galectin-3: A Cardiomyocyte Antiapoptotic Mediator at 24-Hour Post Myocardial Infarction. Cell Physiol Biochem. 2020;54:287-302 pubmed publisher
Kubacka M, Zadrozna M, Nowak B, Kotańska M, Filipek B, Waszkielewicz A, et al. Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist. Hypertens Res. 2019;: pubmed publisher
Seawright J, Sridharan V, Landes R, Cao M, Singh P, Koturbash I, et al. Effects of low-dose oxygen ions and protons on cardiac function and structure in male C57BL/6J mice. Life Sci Space Res (Amst). 2019;20:72-84 pubmed publisher
Zhang L, Zhang R, Tien C, Chan R, Sugi K, Fu C, et al. REV-ERBα ameliorates heart failure through transcription repression. JCI Insight. 2017;2: pubmed publisher
Prysyazhna O, Burgoyne J, Scotcher J, Grover S, Kass D, Eaton P. Phosphodiesterase 5 Inhibition Limits Doxorubicin-induced Heart Failure by Attenuating Protein Kinase G I? Oxidation. J Biol Chem. 2016;291:17427-36 pubmed publisher
Tejada T, Tan L, Torres R, Calvert J, Lambert J, Zaidi M, et al. IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarction. Proc Natl Acad Sci U S A. 2016;113:6949-54 pubmed publisher
Mohamed R, Morimoto S, Ibrahim I, Zhan D, Du C, Arioka M, et al. GSK-3? heterozygous knockout is cardioprotective in a knockin mouse model of familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2016;310:H1808-15 pubmed publisher
Herman E, Knapton A, Liu Y, Lipshultz S, Estis J, Todd J, et al. The influence of age on serum concentrations of cardiac troponin I: results in rats, monkeys, and commercial sera. Toxicol Pathol. 2014;42:888-96 pubmed publisher
Fujino T, Muhib S, Sato N, Hasebe N. Silencing of p53 RNA through transarterial delivery ameliorates renal tubular injury and downregulates GSK-3β expression after ischemia-reperfusion injury. Am J Physiol Renal Physiol. 2013;305:F1617-27 pubmed publisher
Koch S, Tranter M, Robbins N, Luther K, Singh U, Jiang M, et al. Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model. J Cardiovasc Pharmacol Ther. 2013;18:280-9 pubmed publisher
Lai N, Gao M, Tang E, Tang R, Guo T, Dalton N, et al. Pressure overload-induced cardiac remodeling and dysfunction in the absence of interleukin 6 in mice. Lab Invest. 2012;92:1518-26 pubmed publisher
Herman E, Knapton A, ROSEN E, Thompson K, Rosenzweig B, Estis J, et al. A multifaceted evaluation of imatinib-induced cardiotoxicity in the rat. Toxicol Pathol. 2011;39:1091-106 pubmed publisher
Zaidi S, Huang Q, Momen A, Riazi A, Husain M. Growth differentiation factor 5 regulates cardiac repair after myocardial infarction. J Am Coll Cardiol. 2010;55:135-43 pubmed publisher
Niu J, Azfer A, Deucher M, Goldschmidt Clermont P, Kolattukudy P. Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1. J Mol Cell Cardiol. 2006;40:810-20 pubmed
Lien Y, Lin S, Nithipongvanitch R, Oberley T, Noel T, Zhao Q, et al. Tumor necrosis factor receptor deficiency exacerbated Adriamycin-induced cardiomyocytes apoptosis: an insight into the Fas connection. Mol Cancer Ther. 2006;5:261-9 pubmed
product information
master code :
4827-30-K
SKU :
4827-30-K
product name :
CardioTACS In Situ Apoptosis Detection Kit
unit size :
30 Tests
target :
TUNEL Assays
category :
Activity Assays
top caption :
CardioTACS In Situ Apoptosis Detection Kit_Rat Heart Tissue_4827-30-K
USD :
509 USD
storage :
The product requires storage at -20 to -70 ░C, 2 - 8 ░C, and room temperature. Consult the product insert for specific storage temperatures.áDo not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.